(Q40744414)

English

Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.

scientific article published on 28 April 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

3

object named as

Robert D Brook

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

9

object named as

David E Newby

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Julie A Anderson

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Peter M A Calverley

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Bartolome R Celli

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Courtney Crim

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Fernando Martinez

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Julie Yates

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

SUMMIT Investigators

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

language of work or name

0 references

publication date

28 April 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

387

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

10030

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1817-1826

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality in COPD: Role of comorbidities.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Complex chronic comorbidities of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid decline in FEV1. A new risk factor for coronary heart disease mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular dysfunction in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Physical activity in patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular events in patients with COPD: TORCH study results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Spirometric reference values from a sample of the general U.S. population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930069-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(16)30069-1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27203508%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40744414&oldid=1576957523"